跳至主要内容
临床试验/NCT04021602
NCT04021602已完成不适用

Diabetes Prevention Program Feasibility Study of Breastfeeding

University of Kansas Medical Center2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2019年9月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
2
主要终点
Change in Arterial Blood Pressure

研究概览

简要总结

The purpose of this study is to learn about the impact of the Diabetes Prevention Program (DPP) coupled with intensive breastfeeding support to help overweight or obese pregnant women lose weight postpartum, improve their blood sugars and blood pressure, and increase duration of breastfeeding their infant.

详细描述

This pilot randomized controlled trial seeks to determine the feasibility and efficacy of a combined breastfeeding, DPP-based program in a cohort of overweight/obese women to be followed during pregnancy through 6 months postpartum. The pilot trial will have three study arms: DPP + breastfeeding (Tx1), DPP only (Tx2), and usual care (Tx3). Specific aims are: 1) To test the efficacy of Tx1 to improve 6-month postpartum weight loss among women with a BMI >/= 25. 2) To test the efficacy of Tx1 to improve 6-month postpartum mean blood glucose (HbA1c) and mean arterial blood pressure among women with a BMI >/= 25. 3) To test the efficacy of Tx1 to increase any breastfeeding through 6 months postpartum among women with a BMI >/= 25.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Pregnant, 1st trimester or early 2nd trimester
  • •Interested in breastfeeding
  • •BMI >/= 25 and <35
  • •Able to read and understand English
  • •Able to learn and use Facebook
  • •Able to learn and use Skype, FaceTime or Zoom for virtual meetings
  • •Must have a cell phone

排除标准

  • •Pregnancy complications that require emergency care
  • •Thyroid disease
  • •Multiple gestation
  • •Substance abuse within last 3 years
  • •ART (Assisted Reproductive Technology) pregnancy
  • •Current smoker
  • •Prior bariatric surgery
  • •In weight-loss program within 3 months of conception
  • •BMI >/= 35
  • •Unable to attend intervention / follow-up visits
  • •Unwilling to self-monitor data collection
  • •Unable to complete intervention
  • •Presence of any condition that limits walking
  • •Presence of any condition that limits following diet recommendations
  • •Pregnancies complicated with fetuses diagnosed with lethal malformations / conditions

研究组 & 干预措施

Intervention 1 (Tx1) - DPP + Breastfeeding + Usual Care

Active Comparator

Patients randomized to Tx1 will receive education in both the Diabetes Prevention Program (DPP) and in Breastfeeding. At baseline, this includes 16 DPP sessions (core curriculum), one 2-hour breastfeeding session, and participation in a professional peer support group. The 2-hour breastfeeding session is pre-recorded into four (4) 30-minute sessions and archived on a secure, private Facebook group. Participants will have access to all four breastfeeding sessions by week 24 of pregnancy and they need to complete all sessions by week 30 of pregnancy. At delivery, the patient will receive usual lactation support in the hospital, additional breastfeeding assessment and support (at day 3, day 10, week 3 and week 6), followed by 6 DPP sessions (post-core curriculum).

干预措施: Diabetes Prevention Program (Behavioral)

Intervention 1 (Tx1) - DPP + Breastfeeding + Usual Care

Active Comparator

Patients randomized to Tx1 will receive education in both the Diabetes Prevention Program (DPP) and in Breastfeeding. At baseline, this includes 16 DPP sessions (core curriculum), one 2-hour breastfeeding session, and participation in a professional peer support group. The 2-hour breastfeeding session is pre-recorded into four (4) 30-minute sessions and archived on a secure, private Facebook group. Participants will have access to all four breastfeeding sessions by week 24 of pregnancy and they need to complete all sessions by week 30 of pregnancy. At delivery, the patient will receive usual lactation support in the hospital, additional breastfeeding assessment and support (at day 3, day 10, week 3 and week 6), followed by 6 DPP sessions (post-core curriculum).

干预措施: Breastfeeding Education (Behavioral)

Intervention 1 (Tx1) - DPP + Breastfeeding + Usual Care

Active Comparator

Patients randomized to Tx1 will receive education in both the Diabetes Prevention Program (DPP) and in Breastfeeding. At baseline, this includes 16 DPP sessions (core curriculum), one 2-hour breastfeeding session, and participation in a professional peer support group. The 2-hour breastfeeding session is pre-recorded into four (4) 30-minute sessions and archived on a secure, private Facebook group. Participants will have access to all four breastfeeding sessions by week 24 of pregnancy and they need to complete all sessions by week 30 of pregnancy. At delivery, the patient will receive usual lactation support in the hospital, additional breastfeeding assessment and support (at day 3, day 10, week 3 and week 6), followed by 6 DPP sessions (post-core curriculum).

干预措施: Usual Care (Behavioral)

Intervention 2 (Tx2) - DPP Only + Usual Care

Active Comparator

Patients randomized to Tx2 will receive education in only the Diabetes Prevention Program. At baseline, this includes 16 DPP sessions (core curriculum). At delivery, the patient will receive usual lactation support in the hospital, followed by 6 DPP sessions (post-core curriculum).

干预措施: Diabetes Prevention Program (Behavioral)

Intervention 2 (Tx2) - DPP Only + Usual Care

Active Comparator

Patients randomized to Tx2 will receive education in only the Diabetes Prevention Program. At baseline, this includes 16 DPP sessions (core curriculum). At delivery, the patient will receive usual lactation support in the hospital, followed by 6 DPP sessions (post-core curriculum).

干预措施: Usual Care (Behavioral)

Intervention 3 (Tx3) - Usual Care Only

Placebo Comparator

Patients randomized to Tx3 will receive only usual standard of care. At baseline, the patient will receive only regular prenatal care provided by their physician. At delivery, the patient will receive standard of care breastfeeding support provided by the hospital.

干预措施: Usual Care (Behavioral)

结局指标

主要结局

Change in Arterial Blood Pressure

时间窗: At baseline, at delivery, and at 6 months postpartum

The study team will measure mean arterial blood pressure at baseline and at 6 months postpartum.

Duration of Breastfeeding

时间窗: At delivery through 6 months postpartum

The study team will measure duration of breastfeeding from delivery through 6 months postpartum.

Change in Weight

时间窗: At baseline and at delivery through 6 months postpartum

The study team will measure maternal weight at baseline, at delivery, and weekly during the postpartum period to allow for meaningful comparisons of weight change among study arms.

Change in HbA1c

时间窗: At baseline and at 6 months postpartum

The study team will measure mean blood glucose at baseline and at 6 months postpartum.

次要结局

  • Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF, Survey)(At baseline and at 6 months postpartum)
  • Kaiser Physical Activity Survey (KPAS, Weighted Total)(At baseline and at 6 months postpartum)
  • Fruit & Vegetable Intake Screener (EATS)(At baseline and at 6 months postpartum)
  • Edinburgh Postnatal Depression Scale (EPDS)(Postpartum)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lisette Jacobson

Assistant Professor, Preventive Medicine

University of Kansas Medical Center

研究点 (2)

Loading locations...

相似试验